• Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

UBS Lux Equity Fund - Health Care USD

+ Add to Watchlist

UBFW:GR

153.7700 EUR 1.0500 0.69%

As of 15:45:07 ET on 07/11/2014.

Snapshot for UBS Lux Equity Fund - Health Care USD (UBFW)

Open: 154.7900 High - Low: 156.4900 - 153.6300 Primary Exchange: Berlin
Volume: 0 52-Week Range: 122.7200 - 158.0000 Beta vs MXWO0HC: 0.8176

ETF Chart for UBFW

No chart data available.
  • UBFW:GR 154.0960
  • 1D
  • 1M
  • 1Y
152.7200
Interactive UBFW Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBFW

UBS Lux Equity Fund - Health Care USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of large and medium-sized companies from the health care sector, which includes pharmaceuticals, biotechnology, hospital supplies, medical technology, and health care services.

Inception Date: 1998-05-27 Telephone: 352-44-10-10-1 Tel
Managers: SCOTT D WILKIN
Web Site: www.ubs.com

Fundamentals for UBFW

NAV -
Assets (M) (on 2014-07-10) 145.5429
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for UBFW

No dividends reported

Performance for UBFW

1-Month +1.94% 1-Year +20.00%
3-Month +13.84% 3-Year +17.99%
Year To Date +16.22% 5-Year +17.25%
Expense Ratio 2.11

Top Fund Holdings for UBFW

Filing Date: 04/30/2014
Name Position Value % of Total
Novartis AG 116,903 10,130,841 7.256%
Johnson & Johnson 97,500 9,875,775 7.074%
Roche Holding AG 30,320 8,884,729 6.364%
Eli Lilly & Co 120,000 7,092,000 5.080%
Gilead Sciences Inc 85,700 6,726,593 4.818%
Merck & Co Inc 114,612 6,711,679 4.807%
UnitedHealth Group Inc 85,400 6,408,416 4.590%
Allergan Inc/United States 30,500 5,058,120 3.623%
Pfizer Inc 160,312 5,014,559 3.592%
Novo Nordisk A/S 105,468 4,755,126 3.406%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil